NORTH CHICAGO, Ill., March 26, 2026 /PRNewswire/ -- Rosalind Franklin University announced today that Paige Arneson-Wissink, PhD, assistant professor of...
Arora brings experience scaling SaaS and AI platforms as Luma accelerates growth, serving 160M patients across 1,300+ health systems by...
– Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton Syndrome...
– Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton Syndrome...
Reputation 800 Award HNL Lab Medicine Earns Reputation 800 Award ALLENTOWN, Pa., March 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab...
Reputation 800 Award HNL Lab Medicine Earns Reputation 800 Award ALLENTOWN, Pa., March 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab...
Virtual Event will feature Key Opinion Leaders (KOLs) Richard DiPaolo, PhD, and Jonathan Kay, MD, FACP, MACR Cue Biopharma management and...
Virtual Event will feature Key Opinion Leaders (KOLs) Richard DiPaolo, PhD, and Jonathan Kay, MD, FACP, MACR Cue Biopharma management and...
Iconic Popsicle® Flavors Reimagined as Ready-to-Drink Hard Beverages Through New Licensing Agreement NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) --...
Backed by strong diagnostics market growth and industry consolidation, the transaction positions Axonia Medical to expand across PCR, microbiology, and...
SHANGHAI, March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization...
The increase in median overall survival among women treated with IMNN-001 in the OVATION 2 trial rose from the previously...
HAMILTON, BM / ACCESS Newswire / March 24, 2026 / Altamira Therapeutics ("Altamira" or the "Company") (OTCID:CYTOF) today announced that...
HAMILTON, BM / ACCESS Newswire / March 24, 2026 / Altamira Therapeutics ("Altamira" or the "Company") (OTCID:CYTOF) today announced that...
LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with...
Callio Therapeutics is actively developing a pipeline of promising dual-payload ADCs featuring rationally designed payload combinations for hard-to-treat tumors CLIO-8221...
-- Dr. Ashworth Brings Decades of Scientific and Clinical Experience Translating Synthetic Lethality Discoveries into Precision Cancer Therapies -- SOUTH...
Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR...
PLANO, Texas, March 19, 2026 /PRNewswire/ -- LiquidLabor, a technology company focused on providing the infrastructure staffing agencies need to...
STAFFORD, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused...